ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1609

The Incidence Rate of Spondyloarthritis in Slovenia

Natasa Potocnik Pucelj1, Alojzija Hočevar1, Rok Jese1, Ziga Rotar2 and Matija Tomšič3, 1Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, 2BioRx.si, Ljubljana, Slovenia, Ljubljana, Slovenia, 3Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: epidemiologic methods and spondylarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: Spondyloarthritides (SpA) are heterogeneous group of inflammatory diseases, affecting both, axial and peripheral skeleton. Incidence studies in SpA are sparse. There is no data for peripheral SpA as an entity. In axial SpA, recent incidence study reported a decrease of the incidence over decades (1). As data for our country are lacking, we aimed to determine the incidence of SpA in a well defined country region.

Methods:

The study was conducted at rheumatology department of an integrated secondary/tertiary teaching hospital, which provides services to region of around 704,000 adult residents. A retrospective chart review of adult patients diagnosed with SpA for the first time between January 2014 and December 2016 was performed. Potential cases were ascertained by searching the electronic medical records for ICD-10 codes M02*, M07*, M13*, M45*, K50*, K51*and L40*. SpA cases were further stratified into axial and peripheral subgroup. The annual incidence rate of SpA was calculated.

Results: During the three year period we identified 294 new SpA cases (55.1% males, median (IQR) age 46.7 (35.0-57.7) years). We diagnosed ankylosing spondylitis, psoriatic arthritis, reactive arthritis, enteropathic arthritis and undifferentiated SpA in 22.4%, 39.8%, 7.1%, 3.7%, and 26.9% cases, respectively. We classified 98 patients (33.3%) with axial SpA and the rests with peripheral SpA. Characteristics of SpA cohort and both subgroups are presented in Table 1. The estimated annual incidence rate of SpA in our region was 13.9 cases per 100,000 adults per year (95% CI 12.4-15.6), in axial SpA 4.6 per 100,000 adults (95% CI 3.8-5.6), and in peripheral SpA 9.3 per 100,000 adults (95% CI 8.0-10.6). Gender specific incidence rates are presented in Table 1.

Table 1: Characteristics of Spodyloarthritides

Characteristics

All SpA

Peripheral SpA

Axial SpA

No. (%) of cases

294 (100%)

196 (66.7%)

98 (33.3%)

Male gender (%)

162 (55.1%)

95 (48.5%)

67 (67.4%)

Age (years)#

46.7 (35.0-57.7)

49.9 (36.4-58.6)

39.9 (33.7-55.8)

Symptom duration (months)#

7.1 (1.9-24.7)

3.5 (1.0-12.1)

31.7 (10.8-73.2)

HLA B27 positivity (%)

158/261 (60.5%)

81/166 (48.8%)

77/95 (81.1%)

Incidence rate&

13.9 (12.4-15.6)

9.3 (8.0-10.6)

4.6 (3.8-5.6)

Incidence in females&

12.2 (10.2-14.4)

9.3 (7.6-11.3)

2.9 (2.0-4.0)

Incidence in males&

15.8 (13.5-18.3)

9.2 (7.5-11.3)

6.5 (5.1-8.2)

Legend: SpA spondyloarthritis; # median (IQR); & incidence per 100,000 adults per year and 95% confidence interval.

Conclusion: The incidence rate of SpA is similar to the incidence of rheumatoid arthritis in our country (2). Peripheral SpA is two times more frequent than axial SpA.

References:

1) Wright KA, Crowson CS, Michet CJ, Matteson EL: Time trends in incidence, clinical features and cardiovascular disease in ankylosing spondylitis over three decades: a population-based study. Arthritis Care Res (Hoboken) 2015; 67:836-841.

2) Ješe R, Perdan Pirkmajer K, Hočevar A, Rotar Ž, Markez S, Pavić Nikolić M, et al. The Incidence Rate of Rheumatoid Arthritis in Slovenia. (2018 ACR submitted abstract)


Disclosure: N. Potocnik Pucelj, None; A. Hočevar, None; R. Jese, None; Z. Rotar, None; M. Tomšič, None.

To cite this abstract in AMA style:

Potocnik Pucelj N, Hočevar A, Jese R, Rotar Z, Tomšič M. The Incidence Rate of Spondyloarthritis in Slovenia [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/the-incidence-rate-of-spondyloarthritis-in-slovenia/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-incidence-rate-of-spondyloarthritis-in-slovenia/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology